Fig. 2

Prognosis prediction performance of MKI in diverse cancers measured using GEPIA2 (a–e) and Kaplan–Meier Plot (f–i). a Survival heatmap for MKI in 33 TCGA-derived cancers. Heatmap showing log10 HRs for MKI67. Blue and red blocks represent decreased and increased risks, separately. Rectangles with frames indicate the significance upon prognosis analysis. DFS and OS curves for b LIHC (n = 362), c KIRP (n = 281), d ACC (n = 76), e LGG (n = 514). OS and PFS survival curves in f liver cancer (n = 364, n = 316), g BC (n = 1402, n = 3951), h ovarian cancer (n = 1656, n = 1435), and i lung cancer (n = 1925, n = 982). OS overall survival, RFS relapse-free survival, DFS disease-free survival, PFS progression-free survival